MENU
Speakers

  • Anitaben Tailor, Ph.D.
    Anitaben Tailor, Ph.D.
    Biology Technical Marketing, Merck
    BIOGRAPHY
  • Brian McFarlin, Ph.D.
    Brian McFarlin, Ph.D.
    Professor and Associate Dean, University of North Texas
    BIOGRAPHY
  • Pei-Han Chung, Ph.D.
    Pei-Han Chung, Ph.D.
    Associate Director, Pharmacology, Elixiron Immunotherapeutics Inc.
    BIOGRAPHY
  • Kwang-Sung Ahn, Ph.D.
    Kwang-Sung Ahn, Ph.D.
    CEO, PDXen Biosystems Co.
    BIOGRAPHY
  • Lucy Ashley (Moderator)
    Lucy Ashley (Moderator)
    Head of Immunoassay Platform Solutions, Asia Pacific, Merck
    BIOGRAPHY
18 June 2021 | 10:30am-2:30pm (SGT)

New Insights Into Disease Through Ultrasensitive Detection Technology: When Every Molecule Matters

Our Merck Virtual Symposium is an event organized across Asia Pacific with the aim to share scientific knowledge and provide a discourse on how ultrasensitive Single Molecule Counting (SMC™) technology can empower life science research in biomarker discovery, disease pathogenesis, and drug development. Specifically, recent advances in ultrasensitive immunoassay technologies allow new insights through detection of previously undetectable novel biomarkers and better characterization of existing biomarkers – accelerating the research and development effort for the betterment of lives.

In this symposium, you will hear from esteemed speakers from industry, academia, biopharma, and contract research organizations (CRO) on how ultrasensitive SMC™ technology empowers their research.

Topics to be covered include:

  • Advances in ultrasensitive immunoassay technology
  • SMC™ utility in acceleration of drug development programs
  • Pharmacokinetics & Pharmacodynamics (PK/PD) and Immunogenicity
  • Profile of immunological biomarkers during muscle injury and recovery
  • IFN-γ in serum/plasma as a biomarker for disease progression
  • SARS-CoV-2 biomarkers and microbiome profile in patient’s saliva 

Join us online to learn and interact with our panel speakers in the live Q&A sessions and grab the opportunity to have a scientific discussion in the “Ask The Expert” session in the Networking Lounge. Also, check out our Exhibition Hall to explore our innovative and award-winning protein portfolio*.

At Merck, our purpose is to solve the toughest problems in life science by collaborating with the global scientific community. Through that, we aim to accelerate access to better health for people everywhere. We look forward to having you in this informative and timely event!

For Research Use Only. Not For Use In Diagnostic Procedures

*MilliporeSigma was named Protein Supplier of the Year 2021 by CiteAb

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada


Speakers
  • Anitaben Tailor, Ph.D.

    Biology Technical Marketing, Merck
    BIOGRAPHY
  • Brian McFarlin, Ph.D.

    Professor and Associate Dean, University of North Texas
    BIOGRAPHY
  • Pei-Han Chung, Ph.D.

    Associate Director, Pharmacology, Elixiron Immunotherapeutics Inc.
    BIOGRAPHY
  • Kwang-Sung Ahn, Ph.D.

    CEO, PDXen Biosystems Co.
    BIOGRAPHY
  • Lucy Ashley (Moderator)

    Head of Immunoassay Platform Solutions, Asia Pacific, Merck
    BIOGRAPHY

Show Resources
Agenda
  • Use of SARS-CoV-2 patient's saliva for the diagnosis of infection and monitoring the disease progression based on oral IgG, inflammatory cytokines, and oral microbiome profile
    18 June 2021 | 1:45pm - 2:30pm (SGT)
    Use of SARS-CoV-2 patient's saliva for the diagnosis of infection and monitoring the disease progression based on oral IgG, inflammatory cytokines, and oral microbiome profile
    Kwang-Sung Ahn, Ph.D.
    CEO, PDXen Biosystems Co.
    BIOGRAPHY
  • IFN-γ Level in Plasma or Serum Measured by SMC™ Technology could be used as Disease Biomarker
    18 June 2021 | 1:00pm - 1:45pm (SGT)
    IFN-γ Level in Plasma or Serum Measured by SMC™ Technology could be used as Disease Biomarker
    Pei-Han Chung, Ph.D.
    Associate Director, Pharmacology, Elixiron Immunotherapeutics Inc.
    BIOGRAPHY
  • Optimizing Muscle Injury Recovery Using Ultra-Sensitive Biomarker Detection
    18 June 2021 | 11:30am - 12:15pm (SGT)
    Optimizing Muscle Injury Recovery Using Ultra-Sensitive Biomarker Detection
    Brian McFarlin, Ph.D.
    Professor and Associate Dean, University of North Texas
    BIOGRAPHY
  • Single Molecule Counting (SMC™) Technology Provides a Better Biological and Clinical Relevance to Accelerate Drug Development Programs
    18 June 2021 | 10:30am - 11:30am (SGT)
    Single Molecule Counting (SMC™) Technology Provides a Better Biological and Clinical Relevance to Accelerate Drug Development Programs
    Anitaben Tailor, Ph.D.
    Biology Technical Marketing, Merck
    BIOGRAPHY
Help

Show Resources